Hydrochlorothiazide: all 191 studies that test it
Page 2 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Chlorthalidone and HCTZ Impacts on Platelet ActivationStatus unknownNCT02100462Phase 4
- Non-invasive Haemodynamic Assessment in HypertensionCompletedNCT01996085Not applicable
- Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal FunctionStatus unknownNCT01977430Phase 4
- Pharmacokinetic Interactions of Losartan and HydrochlorothiazideCompletedNCT01858623Not applicable
- Drug Interaction Between Irbesartan and HydrochlorothiazideCompletedNCT01858610Not applicable
- Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic SyndromeCompletedNCT01819220Phase 4
- Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)CompletedNCT01767298Not applicable
- Pharmacokinetic Interactions of Valsartan and HydrochlorothiazideCompletedNCT01767259Not applicable
- EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative NetworkWithdrawnNCT01748123Phase 4
- Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted ConditionsCompletedNCT01712139Not applicable
- Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed ConditionsCompletedNCT01712126Not applicable
- Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + HydrochlorothiazideCompletedNCT01692717Phase 1
- Safety and Efficacy of the Combination of Loop With Thiazide-type Diuretics in Patients With Decompensated Heart FailureCompletedNCT01647932Phase 3
- Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance ArteriesWithdrawnNCT01480791Phase 2
- Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 HypertensionCompletedNCT01415505Phase 3
- Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic SyndromeStatus unknownNCT01271374Phase 4
- Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and LisinoprilCompletedNCT01258764Not applicable
- Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fed ConditionsCompletedNCT01218724Phase 1
- Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.CompletedNCT01218711Phase 1
- Recurrent Stroke Prevention Clinical Outcome StudyStatus unknownNCT01198496Phase 4
- Telmisartan, Amlodipine and Flow Mediated DilationStatus unknownNCT01180205Phase 4
- Treatment of Adiposity Related hypErTension (TARGET)CompletedNCT01138423Phase 4
- Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus AmlodipineCompletedNCT01113047Phase 3
- Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted ConditionsCompletedNCT01102478Not applicable
- Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II HypertensionCompletedNCT01070030Phase 4
- A Clinical Study With Aliskiren Alone or in Combination Therapy With Diuretic Hctz in Venezuelan Hypertensive Patients.CompletedNCT01056731Phase 4
- Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe HypertensionCompletedNCT01012479Phase 4
- Study to Determine the Effects of Nebivolol and Hydrochlorothiazide in African Americans With HypertensionCompletedNCT00999752Not applicable
- Monotherapy Versus Dual Therapy for Initial Treatment for HypertensionStatus unknownNCT00994617Phase 4
- A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male VolunteersCompletedNCT00923533Phase 1
- Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT00872586Phase 3
- Renin Profiling in Selection of Initial Antihypertensive DrugCompletedNCT00834600Not applicable
- Reducing the Overall Risk Level in Patients Suffering From Metabolic SyndromeCompletedNCT00821574Phase 4
- Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting ConditionsCompletedNCT00778726Not applicable
- Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed ConditionsCompletedNCT00778674Not applicable
- Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting ConditionsCompletedNCT00776646Not applicable
- Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.CompletedNCT00775814Phase 4
- Regression of Fatty Heart by Valsartan TherapyWithdrawnNCT00745953Phase 4
- A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or HydrochlorothiazideCompletedNCT00671424Phase 1
- Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive PatientsCompletedNCT00670566Phase 4
- Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mgCompletedNCT00649324Early Phase 1
- Factorial Study of Metoprolol Succinate TOPROL-XL (324A)CompletedNCT00642096Phase 3
- Dose-Dependent Effect of Thiazide in Dent's Disease HypercalciuriaTerminatedNCT00638482Phase 2/3
- Antihypertensive Response to Losartan and Genetic PolymorphismsCompletedNCT00617877Not applicable
- The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)CompletedNCT00607035Phase 4
- Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With HypertensionCompletedNCT00548067Phase 3
- Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on AmlodipineCompletedNCT00509470Phase 4
- Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate HypertensionCompletedNCT00500604Phase 4
- Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 MonthsCompletedNCT00487123Phase 4
- Irbesartan/Hydrochlorothiazide National Taiwan University Hospital ListingCompletedNCT00443612Phase 4
- Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive PatientsCompletedNCT00426478Phase 4
- Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients HypertensionCompletedNCT00425997Phase 4
- Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina PectorisTerminatedNCT00424801Not applicable
- Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in HypertensionCompletedNCT00400777Phase 4
- Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic SubjectsTerminatedNCT00388388Phase 2
- Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With HypertensionCompletedNCT00387517Phase 3
- A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive PatientsCompletedNCT00386139Phase 3
- Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and ProteinuriaSuspendedNCT00369538Phase 4
- Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT00367094Phase 3
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus HydrochlorothiazideCompletedNCT00360178Phase 3
- Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential HypertensionCompletedNCT00355589Phase 3
- Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)CompletedNCT00338936Phase 3
- 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe HypertensionCompletedNCT00327587Phase 3
- A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)CompletedNCT00311740Phase 3
- Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and PlaceboCompletedNCT00282178Phase 2
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With HypertensionCompletedNCT00280540Phase 4
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With HypertensionCompletedNCT00277472Phase 4
- PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT00274638Phase 4
- Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe HypertensionCompletedNCT00273299Phase 3
- Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)CompletedNCT00263393Phase 4
- Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate HypertensionCompletedNCT00263003Phase 3
- Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential HypertensionCompletedNCT00257491Phase 3
- A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.CompletedNCT00250562Phase 3
- Behavioural Treatment of HypertensionCompletedNCT00247910Not applicable
- A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With HypertensionCompletedNCT00241007Phase 3
- PHARES Study: Management of Resistant HypertensionCompletedNCT00224549Phase 4
- Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
- Olmesartan in Essential HypertensionCompletedNCT00185172Phase 3
- Hypertension and Cardiovascular Risk FactorsCompletedNCT00171782Phase 4
- Antialbuminuric Effects of Valsartan and LisinoprilTerminatedNCT00171600Phase 4
- Antiproteinuric Effect of Valsartan and LisinoprilCompletedNCT00171574Phase 4
- Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.CompletedNCT00171561Phase 4
- VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan MedoxomilCompletedNCT00171015Phase 3
- Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan AloneCompletedNCT00170989Phase 3
- A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic SyndromeCompletedNCT00170937Phase 4
- Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II DiabetesCompletedNCT00160160Not applicable
- 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential HypertensionCompletedNCT00153049Phase 2
- Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mgCompletedNCT00146341Phase 3
- INVEST: INternational VErapamil SR Trandolapril STudyCompletedNCT00133692Phase 4
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionCompletedNCT00095550Phase 3
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionCompletedNCT00095394Phase 3